HeraMED Limited (ASX:HMD)

HeraMED Ratios and Metrics

Market cap in millions AUD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 6, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	55	39	18	8	30	45
Market Cap Growth	233.24%	120.00%	127.12%	-74.58%	-32.86%	173.72%
Enterprise Value	54	38	16	7	28	43
Last Close Price	0.05	0.04	0.02	0.02	0.12	0.23
PS Ratio	128.45	89.27	36.39	12.72	94.17	379.07
PB Ratio	59.55	41.38	6.32	11.24	7.20	-309.93
P/TBV Ratio	59.55	41.38	6.32	11.24	7.20	-
EV/Sales Ratio	125.27	87.05	33.87	11.10	86.59	357.97
Debt / Equity Ratio	-	-	0.03	0.38	0.06	-32.25
Net Debt / Equity Ratio	-1.47	-1.47	-1.10	-1.23	-0.86	1.57
Net Debt / EBITDA Ratio	0.36	0.36	0.56	0.13	0.78	0.04
Net Debt / FCF Ratio	0.38	0.38	0.63	0.15	0.96	0.05
Asset Turnover	0.14	0.14	0.13	0.13	0.05	0.02
Inventory Turnover	-	-	-	0.79	0.60	0.54
Quick Ratio	4.38	4.38	3.09	0.95	3.43	0.88
Current Ratio	4.49	4.49	3.49	1.28	3.85	0.94
Return on Equity (ROE)	-223.20%	-223.20%	-317.64%	-277.44%	-354.24%	-603.42%
Return on Assets (ROA)	-80.46%	-80.46%	-91.62%	-92.11%	-45.46%	-63.26%
Return on Capital Employed (ROCE)	-329.10%	-329.10%	-158.90%	-460.60%	-94.50%	-888.70%
Earnings Yield	-7.45%	-10.72%	-31.35%	-87.87%	-23.67%	-17.38%
FCF Yield	-	-9.49%	-27.49%	-74.11%	-12.44%	-9.90%
Buyback Yield / Dilution	-101.27%	-101.27%	-104.14%	-21.65%	-22.61%	-38.84%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.